# Potassium Citrate

NDC: 0245-0071
Generic name: potassium citrate
Labeler / Manufacturer: Upsher-Smith Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20060901
Marketing ended: 20270731
FDA application: NDA019071

## Active ingredients

- POTASSIUM CITRATE: 10 meq/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0245-0071"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0245-0071
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2215dc1d-0b5a-469e-9b51-4d7480a51078